Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 23 - Number 1







Review Article

Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies

, 23(1): 95 - 107

Chandrika Gowda, Mansi Sachdev, Sunil Muthusami, Malika Kapadia, Lidija Petrovic-Dovat, Melanie Hartman, Yali Ding, Chunhua Song, Jonathon L. Payne, Bi-Hua Tan and Sinisa Dovat


DOI: 10.2174/1381612822666161006154311


Review Article

Targeting Notch as a Therapeutic Approach for Human Malignancies

, 23(1): 108 - 134

Natalia Platonova, Elena Lesma, Andrea Basile, Monica Bignotto, Silvia Garavelli, Maria Teresa Palano, Adriana Moschini, Antonino Neri, Michela Colombo and Raffaella Chiaramonte


DOI: 10.2174/1381612822666161006160524







Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog